Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-29

Clinical Trial Update: Effects of Transcutaneous Vagus Nerve Stimulation (taVNS) in Individuals With Primary Dysmenorrhea [NA]

View source ↗

Summary

A completed clinical trial evaluated transcutaneous vagus nerve stimulation (taVNS) for primary dysmenorrhea; no results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous Vagus Nerve Stimulation (taVNS)

Snippet

Sponsor: Artvin Coruh University | Conditions: Dysmenorrhea Primary, Pain | NA | Status: COMPLETED